Skip to main content

Science to Startup

Science2Startup®

S2S is a forum for top scientists from around the world to present their ideas and interact with leading investors and executives in the Boston biotechnology hub.

Mark your calendar!

Connecting world-class science with top investors

Submissions received
0
Projects presented
0
VC investors attended
0
Companies funded
0 +
Countries represented
0 +

Science2Startup Symposium

S2S is an invitation-only symposium featuring the most innovative therapeutics startup ideas from the world’s top research institutions.

Keynote speaker

Coming soon!

PANELS

featuring biotech ecosystem leaders

Presentations

by selected Entrepreneurs

Networking Reception
opportunities throughout the event

Our process

November 2026
Proposal Submissions Due
Academic researchers are invited to submit a one page overview of their therapeutic startup ideas.
December 2026
Semi-Finalists Selected
A subset of the applicants will be invited to submit a short slide deck to support a deeper review by the Advisory Committee.
Late February 2027
Presenters Selected
Selected researchers will be invited to present their work  at the S2S Symposium.
March 2027
Mentorship Program Begins
Each Presenter will work with matched advisors to refine their company strategy and presentation.
May 2027
Science2Startup Symposium
A full day event featuring the selected Presenters, topical discussions by industry leaders, and many networking opportunities with the biotech investors and operators in attendance.

Advisors

S2S participants engage with leading biotech investors.

Jess_Alston_Lifestyle
Partner, F-Prime
Jessica Alston, PhD
Matt Cohen
Managing Partner, OUP
Matt Cohen, PhD
Deb Palestrant, PhD
Partner & Executive Chair, 4:59 Initiative, 5AM Ventures
Deb Palestrant, PhD
Laura Tadvalkar, PhD
Managing Director, RA Capital Management
Laura Tadvalkar, PhD
Jason Rhodes, MBA
Partner, Atlas Venture
Jason Rhodes, MBA

Presenters

Meet our S2S Class of 2027 Presenters

Presenters will be announced in March 2027! 
Jeffrey R. Millman, Ph.D.
Co-founder and CEO IsletForge Innovations
Jeffrey R. Millman, Ph.D.
Christine D. Baker
Co-Founder and CEO Saatient Therapeutics, Inc.
Christine D. Baker, M.B.A
Mandy Pinheiro, Ph.D.
Co-Founder Evina Biosciences
Mandy Pinheiro, Ph.D.
Shawn Iadonato, Ph.D.
CEO CounterX Therapeutics
Shawn Iadonato, Ph.D.
Hunter Newman, Ph.D.
Co-Founder & CEO OsetoCure Therapeutics, Inc.
Hunter Newman, Ph.D.
Stephen Chan, M.D., Ph.D.
Professor and Director Vascular Medicine Institute at the University of Pittsburgh, CSO Amlysion Therapeutics
Stephen Chan, M.D., Ph.D.
Hiroyuki Nakai, M.D., Ph.D.
Founder, President & CEO NeoSakura BTX
Hiroyuki Nakai, M.D., Ph.D.
Jennifer Beecham
COO and Co-Founder Rho Bio
Jennifer Beecham

Submission Form

Successful S2S submissions are those that identify discoveries and technologies with the highest therapeutic potential and a tractable development path to clinical proof of concept. A one-page document outlining the topics listed below is required (click here for detailed instructions). Submissions are due by Friday, November 14th.

  • Foundational scientific rationale and description of therapeutic approach
  • Differentiation over existing/competitive approaches with supporting data
  • Near-term research plan (next 12 months) and resources required

"*" indicates required fields

Step 1 of 2

Contact Details

Name*
Email*

Hosted by

Science2Startup is generously sponsored by:

CitrinCooperman Logo
Platinum Sponsor
Deloitte-Logo
Platinum sponsor
SVB_logo
Gold sponsor
Colliers Logo
Gold sponsor

Science2Startup is generously sponsored by:

Lilly Labs logo
DIAMOND SPONSOR
CitrinCooperman Logo
Platinum Sponsor
Deloitte-Logo
Platinum sponsor
Goodwin logo
Platinum sponsor
oRCHESTRA lOGO
Platinum sponsor
SVB_logo
Gold sponsor
Colliers Logo
Gold sponsor

Thank you!

Thanks to all who joined S2S on May 14, 2025.

Follow Science2Startup on LinkedIn for updates on S2S 2026!